Fagron Genomics will be participating in the IMCAS World Congress 2027, taking place on 28–30 January 2027 at the Palais des Congrès de Paris, France.
Recognized as the leading congress in dermatology, plastic surgery and aging science, IMCAS brings together physicians, researchers and industry leaders from around the world to share the latest scientific advances and discuss the future of clinical practice.
The Fagron Genomics team will be at Booth H118, where healthcare professionals will be able to explore our complete portfolio of genetic tests, including our two newest solutions: MenoGen, for women’s hormonal health, and W8Gen, for weight management.
As part of the program, Dr. Gustavo Torres de Souza, Lead Geneticist at Fagron Genomics, will present “Weight Optimisation Genetics: GLP-1/GIP Response and Metabolic Profile” in an industry lecture. The session will explore how genetic factors related to appetite, metabolism and body composition may help anticipate response and tolerability to GLP-1/GIP therapies, supporting more personalized approaches to weight management.
We look forward to welcoming dermatologists, plastic surgeons and aesthetic medicine professionals in Paris, and to sharing how genetic insights can support their clinical decisions.
For more information visit https://www.imcas.com/en
